Computational fluid dynamics modelling in cardiovascular medicine.

Morris PD, Narracott A, von Tengg-Kobligk H, Silva Soto DA, Hsiao S, Lungu A, Evans P, Bressloff NW, Lawford PV, Hose DR, Gunn JP. · 2016

Read Computational fluid dynamics modelling in cardiovascular medicine. by Morris PD, Narracott A, von Tengg-Kobligk H, Silva Soto DA, Hsiao S, Lungu A, Evans P, Bressloff NW, Lawford PV, Hose DR, Gunn JP. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4717410.txt.

Introduction

Paul D. Morris, Andrew Narracott, Hendrik von Tengg-Kobligk, and eight colleagues reviewed fluid-flow computing in heart medicine, in Heart in 2016. Computational fluid dynamics simulates how fluids move, a routine tool in safety-critical engineering. Applied to scans of a patient's vessels, it can compute pressures and flows no probe can measure directly, such as the stress blood exerts on vessel walls. The review weighs the method's benefits and obstacles.

Device design already leans on these simulations for stents, valves, and heart pumps. The frontier is personal: models built from one patient's imaging can forecast risk and rehearse treatments virtually. Combined with population models, they could make trials cheaper and safer. The authors also name the blockers, from methods to training, that groups are working through. Their verdict: a new era is coming, provided the groundwork is done honestly.

Catalog record

CREATORMorris PD, Narracott A, von Tengg-Kobligk H, Silva Soto DA, Hsiao S, Lungu A, Evans P, Bressloff NW, Lawford PV, Hose DR, Gunn JP.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4717410

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Computational fluid dynamics modelling in cardiovascular medicine By Paul D Morris, Andrew Narracott, Hendrik von Tengg-Kobligk, Daniel Alejandro Silva Soto, Sarah Hsiao, Angela Lungu, Paul Evans, Neil W Bressloff, Patricia V Lawford, D Rodney Hose, Julian P Gunn Published in: Heart DOI: 10.1136/heartjnl-2015-308044 ABSTRACT This paper reviews the methods, benefits and challenges associated with the adoption and translation of computational fluid dynamics (CFD) modelling within cardiovascular medicine. CFD, a specialist area of mathematics and a branch of fluid mechanics, is used routinely in a diverse range of safety-critical engineering systems, which increasingly is being applied to the cardiovascular system. By facilitating rapid, economical, low-risk prototyping, CFD modelling has already revolutionised research and development of devices such as stents, valve prostheses, and ventricular assist devices. Combined with cardiovascular imaging, CFD simulation enables detailed characterisation of complex physiological pressure and flow fields and the computation of metrics which cannot be directly measured, for example, wall shear stress. CFD models are now being translated into clinical tools for physicians to use across the spectrum of coronary, valvular, congenital, myocardial and peripheral vascular diseases. CFD modelling is apposite for minimally-invasive patient assessment. Patient-specific (incorporating data unique to the individual) and multi-scale (combining models of different length- and time-scales) modelling enables individualised risk prediction and virtual treatment planning. This represents a significant departure from traditional dependence upon registry-based, population-averaged data. Model integration is progressively moving towards ‘digital patient’ or ‘virtual physiological human’ representations. When combined with population-scale numerical models, these models have the potential to reduce the cost, time and risk associated with clinical trials. The adoption of CFD modelling signals a new era in cardiovascular medicine. While potentially highly beneficial, a number of academic and commercial groups are addressing the associated methodological, regulatory, education- and service-related challenges. INTRODUCTION Computational fluid dynamics (CFD) is a well-established tool used in engineering, in many areas of which it has become the primary method for design and analysis. Bioengineers have adopted CFD to study complex physiological flows and have demonstrated their potential.1 There is increasing interest in applying these methods in cardiovascular medicine.2 3 CFD-based techniques are being used to build complex computer representations (in silico models) of the cardiovascular system in health and disease. CFD modelling is a new field within cardiovascular medicine, enhancing diagnostic assessment, device design and clinical trials. It can predict physiological responses to intervention and compute previously unmeasurable haemodynamic parameters.4 As CFD modelling continues to translate into clinical tools, it is important that clinicians understand the principles, benefits and limitations of these techniques. This article explores these topics using state-of-the-art examples in key clinical areas, highlighting applications likely to impact clinical practice within the next 5 years (table 1). [Table: Summary of CFD modelling applications in cardiovascular medicine] WHAT IS CFD? CFD is a specialist area of mathematics and a branch of fluid mechanics. It is used in the design of many safety-critical systems, including aircraft and vehicles, by solving differential equations to simulate fluid flow. A glossary of uesful terms is provided in table 2. [Table: CFD—a glossary of selected useful terminology] For incompressible flows, almost all CFD analyses solve the Navier-Stokes and continuity equations which govern fluid motion. These equations are non-linear, partial differential equations based upon the principle of conservation of mass and momentum. Simplification of these equations yields familiar formulae (eg, those of Bernoulli and Poiseuille); but for complex geometries analytical solutions are not possible, so specialised software applications (CFD solvers) calculate approximate numerical solutions. Non-linearity, due to convective fluid acceleration, makes this challenging, especially in three dimensional (3D) models; so CFD analyses require significant computational power and time. CFD MODEL COMPLEXITY The applications reviewed in this paper focus on 3D CFD analyses of local regions of the vasculature because this is where promising applications are beginning to translate and impact upon clinical medicine. There is a long history of simplification of the governing equations to lower spatial dimensions. Table 3 summarises the relationship between these approaches and provides clinical examples of their use. [Table: A summary of the various orders of CFD modelling applied to the cardiovascular system] 2D analyses typically assume symmetry of the solution about the central axis, 1D models capture variation of the solution along the axial direction only, and 0D representations lump the behaviour of vascular regions into a model with no spatial dimensions, hence the term ‘lumped-parameter models'. Due to the breadth of the literature covering application of these techniques to cardiovascular haemodynamics, the interested reader is referred to recent reviews of the state-of-the-art.45 46 MODEL CONSTRUCTION CFD model construction and solution can be described in seven stages (figure 1): Clinical imaging [Figure: Examples of aortic (A) and coronary (B) in silico computational fluid dynamics (CFD) workflows. (A) The aorta is identified from thoracic MRI (a), segmented and reconstructed (central image). A volumetric mesh is fabricated to fit the patient-specific geometry, shown in detail in panel (b). Accurate flow measurements are extracted from phase-contrast MRI data to inform the boundary conditions applied for CFD simulation, such as the inlet (c). The results are post-processed, details of the flow field are shown in panel (d). 0D models are coupled at the outlets so physiologically feasible flow-pressure relationships are computed at the outlets (e). These can be validated against other measurements, which in a preclinical scenario may be invasive. (B) (and accompanying online video) A coronary angiogram (a) is segmented (b) and reconstructed into a 3D in silico model. A surface and volumetric are fabricated to fit the patient-specific geometry (c). Physiological parameters such as pressure and flow are used to inform the boundary conditions applied for CFD simulation (d). The results (here pressure and flow) are post-processed and useful physiological data are extracted (e). In the preclinical, research setting simulated results are validated against an appropriate standard, for example, invasively measured values (f). (Additional information for video legend): VIRTUheart is an academic project at the University of Sheffield funded by research grants (see virtuheart.com).] A range of medical imaging modalities can be used, including ultrasound, CT, MRI and X-ray angiography. Imaging must provide sufficient anatomical and physiological detail, in an appropriate format and quality, to enable segmentation and data extraction.49 Segmentation and reconstruction Segmentation methods convert medical images to in silico geometries which define the physical bounds of the model region of interest. If images are acquired over a cardiac cycle, anatomical motion can be tracked over segmented regions.50 51 Discretisation Spatial discretisation, or ‘meshing’, divides the geometry into a number of discrete volumetric elements or cells. Temporal discretisation divides the solution into discrete time steps. The accuracy and numerical stability of the analysis are influenced by both spatial and temporal refinement. The fabrication of the mesh, and the level of mesh refinement, are influenced by case- and context-specific factors. The mesh and timestep (ie, spatio-temporal discretisation) must be refined enough to capture the important haemodynamic behaviour of the modelled compartment (the final solution should be independent of mesh parameters), but without excessive refinement because this impacts negatively on computational resource and solution time (see online supplementary table S1). Boundary conditions Because it is impossible to discretise the entire cardiovascular system, the region to be analysed will have at least one inlet and one

Read the complete text